Drug Shortage Report for ANORO ELLIPTA

Last updated on 2020-04-22 History
Report ID 110852
Drug Identification Number 02418401
Brand name ANORO ELLIPTA
Common or Proper name umeclidinium (as bromide) and vilanterol (as trifenatate) dry powder for oral inhalation
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) VILANTEROL UMECLIDINIUM
Strength(s) 25MCG 62.5MCG
Dosage form(s) POWDER
Route of administration INHALATION INHALATION
Packaging size 30
ATC code R03AL
ATC description ADRENERGICS, INHALANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-04-01
Estimated end date Unknown
Actual end date 2020-04-21
Shortage status Resolved
Updated date 2020-04-22
Company comments Re-supply is ongoing with inventory allocated to 50% of regular demand.
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-04-22 French Compare
v5 2020-04-22 English Compare
v4 2020-04-06 French Compare
v3 2020-04-06 English Compare
v2 2020-04-03 French Compare
v1 2020-04-03 English Compare